Research location
Pachuca
Mexico
Advertisement
Research activity in Pachuca
MexicoCureCurrent currently publishes aggregate city-level research activity for this location: 36 trials and 42 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Pachuca
36 linked trials · page 1 of 1A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung CancerNCT03800134 · 2018-12-06 · 1 site observation
ACTIVE_NOT_RECRUITING
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CADNCT02586155 · 2015-11-01 · 2 site observations
COMPLETED
Linagliptin as Add on to Basal Insulin in the ElderlyNCT02240680 · 2014-09-23 · 1 site observation
COMPLETED
Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic NephropathyNCT02065791 · 2014-02-17 · 1 site observation
COMPLETED
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusNCT01991795 · 2014-02-10 · 1 site observation
COMPLETED
A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes MellitusNCT01989754 · 2014-01-16 · 1 site observation
COMPLETED
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 DiabetesNCT02058160 · 2014-01-01 · 1 site observation
COMPLETED
A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart FailureNCT01877915 · 2013-09-10 · 1 site observation
COMPLETED
A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and ExerciseNCT01809327 · 2013-06-04 · 1 site observation
COMPLETED
Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular EventsNCT01730534 · 2013-04-25 · 1 site observation
COMPLETED
A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)NCT01715285 · 2013-02-12 · 1 site observation
COMPLETED
A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic TherapyNCT01691755 · 2012-11-01 · 1 site observation
COMPLETED
A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin AloneNCT01691846 · 2012-10-01 · 1 site observation
COMPLETED
A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin TherapyNCT01649297 · 2012-10-01 · 1 site observation
COMPLETED
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime InsulinNCT01499082 · 2011-12-01 · 1 site observation
COMPLETED
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic TherapyNCT01499095 · 2011-12-01 · 1 site observation
COMPLETED
Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes PatientsNCT01422876 · 2011-08-01 · 1 site observation
COMPLETED
Safety and Efficacy of Galvus as add-on Therapy to Metformin Plus GlimepirideNCT01233622 · 2010-10-01 · 3 site observations
COMPLETED
A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal ImpairmentNCT01043029 · 2010-05-01 · 2 site observations
COMPLETED
A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes MellitusNCT01042769 · 2010-02-01 · 1 site observation
COMPLETED
Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 DiabetesNCT01023581 · 2009-11-01 · 1 site observation
COMPLETED
Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary SyndromeNCT00968708 · 2009-09-01 · 1 site observation
COMPLETED
24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 YearsNCT00976937 · 2009-08-01 · 2 site observations
COMPLETED
Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 DiabetesNCT00954447 · 2009-08-01 · 1 site observation
COMPLETED
Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) TreatmentNCT00949442 · 2009-07-01 · 2 site observations
COMPLETED
Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial DesignNCT00798161 · 2008-12-01 · 1 site observation
COMPLETED
A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.NCT00754988 · 2008-10-01 · 1 site observation
COMPLETED
A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.NCT00502710 · 2007-07-01 · 1 site observation
COMPLETED
Comparison of Two Basal Insulin Therapies for Patients With Type 1 DiabetesNCT00487240 · 2007-06-01 · 1 site observation
COMPLETED
A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and New York Heart Association (NYHA) Class II Heart Failure.NCT00461058 · 2007-05-01 · 1 site observation
COMPLETED
Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 DiabetesNCT00469092 · 2007-05-01 · 1 site observation
COMPLETED
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.NCT00423501 · 2007-02-01 · 1 site observation
COMPLETED
A Study of Aleglitazar in Patients With Type 2 DiabetesNCT00388518 · 2006-11-01 · 1 site observation
COMPLETED
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.NCT00366379 · 2006-07-01 · 1 site observation
COMPLETED
Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADsNCT01486862 · 2005-10-01 · 1 site observation
COMPLETED
A Study of DPP-IV Inhibitor in Patients With Type 2 DiabetesNCT00111670 · 2005-06-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.